HG-1204

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1204

Drug Alias NameCD85K modulator (Human Genome Sciences)FcR-IV modulator (Human Genome Sciences)HM18 modulator (Human Genome Sciences)LIR5 modulator (Human Genome Sciences)leukocyte Ig-like receptor modulator (Human Genome Sciences) +[10]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLeukocyte immunoglobulin-like receptor subfamily B member 3 modulators

TargetsLeukocyte immunoglobulin-like receptor subfamily B member 3

Therapy Area/IndicationsInflammationImmune System DiseasesBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationImmune System DiseasesBone Diseases

Other Information

ATC CodeN/A